@article{d05eb9488fed49cda3b82e95693ff9d9,
title = "Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic",
author = "Patnaik, \{Mrinal M.\} and Terra Lasho and Eric Padron and Kristen McCullough and Aref Al-kali and Ayalew Tefferi and Zeidan, \{Amer M.\} and Naseema Gangat and Michael Savona and Steensma, \{David P.\} and Eric Solary",
note = "Funding Information: Current publication is supported in part by grants from the “The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA”. A.Z. is a Leukemia and Lymphoma Society Scholar in Clinical Research and is also supported by a NCI{\textquoteright}s Cancer Clinical Investigator Team Leadership Award (CCITLA). Research reported in this publication was in part supported by the National Cancer Institute of the National Institutes of Health under Award Number P30 CA016359. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. M.S. is a Leukemia and Lymphoma Society Scholar in Clinical Research. David Steensma is supported by the Edward P. Evans Foundation.",
year = "2020",
month = aug,
day = "1",
doi = "10.1002/ajh.25853",
language = "English (US)",
volume = "95",
pages = "E203--E208",
journal = "American journal of hematology",
issn = "0361-8609",
publisher = "John Wiley and Sons Inc.",
number = "8",
}